Post Approval Study Confirms Clinical Trial Results for HeartMate II® in Destination Therapy

Results presented today at the International Society for Heart and Lung TransplantationMONTREAL, April 25, 2013 – Today, researchers will reveal the latest findings on a post-approval study for destination therapy (DT) at the International Society for Heart and Lung Transplantation (ISHLT)  33rd Annual Meeting and Scientific Sessions in Montreal, Canada. The study focused on comparing commercial results to the multicenter clinical trial conducted from 2005-2010 using the HeartMate II® Left Ventricular Assist Device (LVAD). Results in a commercial patient care setting